Standard BioTools Inc (LAB)
2.155
+0.06
(+2.62%)
USD |
NASDAQ |
Nov 05, 09:32
Standard BioTools Enterprise Value: 468.31M for Nov. 4, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 04, 2024 | 468.31M |
| November 01, 2024 | 427.48M |
| October 31, 2024 | 416.34M |
| October 30, 2024 | 386.65M |
| October 29, 2024 | 338.40M |
| October 28, 2024 | 319.84M |
| October 25, 2024 | 312.42M |
| October 24, 2024 | 330.98M |
| October 23, 2024 | 349.54M |
| October 22, 2024 | 371.81M |
| October 21, 2024 | 386.65M |
| October 18, 2024 | 394.08M |
| October 17, 2024 | 356.96M |
| October 16, 2024 | 390.36M |
| October 15, 2024 | 390.36M |
| October 14, 2024 | 390.36M |
| October 11, 2024 | 390.36M |
| October 10, 2024 | 345.83M |
| October 09, 2024 | 345.83M |
| October 08, 2024 | 356.96M |
| October 07, 2024 | 364.38M |
| October 04, 2024 | 375.52M |
| October 03, 2024 | 360.67M |
| October 02, 2024 | 379.23M |
| October 01, 2024 | 379.23M |
| Date | Value |
|---|---|
| September 30, 2024 | 405.21M |
| September 27, 2024 | 372.99M |
| September 26, 2024 | 365.56M |
| September 25, 2024 | 339.58M |
| September 24, 2024 | 391.54M |
| September 23, 2024 | 354.43M |
| September 20, 2024 | 406.39M |
| September 19, 2024 | 443.50M |
| September 18, 2024 | 413.81M |
| September 17, 2024 | 402.68M |
| September 16, 2024 | 436.08M |
| September 13, 2024 | 424.95M |
| September 12, 2024 | 413.81M |
| September 11, 2024 | 395.25M |
| September 10, 2024 | 402.68M |
| September 09, 2024 | 398.97M |
| September 06, 2024 | 380.41M |
| September 05, 2024 | 387.83M |
| September 04, 2024 | 376.70M |
| September 03, 2024 | 395.25M |
| August 30, 2024 | 450.93M |
| August 29, 2024 | 432.37M |
| August 28, 2024 | 432.37M |
| August 27, 2024 | 469.49M |
| August 26, 2024 | 465.77M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
-57.79M
Minimum
Sep 29 2022
985.09M
Maximum
Mar 28 2024
292.40M
Average
307.97M
Median
Feb 08 2022
Enterprise Value Benchmarks
| Ainos Inc | 9.488M |
| Zomedica Corp | 40.25M |
| LENSAR Inc | 53.81M |
| Intelligent Bio Solutions Inc | 0.0571M |
| Adagio Medical Holdings Inc | 23.48M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -26.94M |
| Revenue (Quarterly) | 44.97M |
| Total Expenses (Quarterly) | 69.27M |
| EPS Diluted (Quarterly) | -0.07 |
| Gross Profit Margin (Quarterly) | 51.73% |
| Profit Margin (Quarterly) | -59.90% |
| Earnings Yield | -32.95% |
| Normalized Earnings Yield | -28.10 |